Displaying 1-9 of 9 result(s).
| Board Name | Posts By boingo99 | Post Created |
|---|---|---|
| NTEK Nanotech Entertainment Inc. | I have a suggestion on how NTEK/ULT | 02/05/2016 12:37:20 PM |
| NTEK Nanotech Entertainment Inc. | Does anyone here use ETrade? They h | 08/31/2015 5:29:42 PM |
| NTEK Nanotech Entertainment Inc. | I don't know how many of you saw th | 06/02/2015 2:57:03 PM |
| NTEK Nanotech Entertainment Inc. | I thought that the ILIE bashers wer | 05/01/2015 10:31:54 AM |
| NTEK Nanotech Entertainment Inc. | Good morning NTEKer"s Talk about ma | 05/01/2015 9:43:30 AM |
| NTEK Nanotech Entertainment Inc. | I guess we forgot to put out the co | 04/17/2015 1:06:38 PM |
| NTEK Nanotech Entertainment Inc. | Alan, I agree 100%, They will do an | 04/13/2015 8:41:46 AM |
| NTEK Nanotech Entertainment Inc. | He was probably trying to get a fa | 04/10/2015 4:11:54 PM |
| NTEK Nanotech Entertainment Inc. | Mr Foley, I like many here apprecia | 04/08/2015 3:29:21 PM |
Recent Articles
- Juniper Networks Unveils 2025 Partner Program for Growth
- Lantern Pharma Launches Advanced AI Module for ADC Development
- Exploring Home Services Market Growth Driven by AI Innovations
- Ambius Triumphs with 20 Accolades at International Awards
- HyperStrong Celebrates Successful Debut on STAR Market
- Haivision Expands Share Purchase Program to Unlock Value
- Market Sentiment Impacted by Trade Strategies and Volatility
- Emerging Trends in Saudi Arabia's Growing Protein Bar Sector
- Understanding the Growth of Satellite Spectrum Monitoring
- Citrus Fiber Market Growth Forecast: Innovations and Insights
- Exciting Growth Ahead for Outdoor Kitchen Appliances Market
- Nayax and SECO Forge New Partnership for Smart Payment Solutions
- Latest Update from Western Resources Corp. on MCTO Status
- Insights into Organogenesis Holdings' Upcoming Financial Report
- Vonlane Launches New Daily Non-Stop Route Between Dallas and Austin
- Leslie’s, Inc. to Release First Quarter Financial Results
- Innovative Developments at Anavex Life Sciences in Drug Patents
- Vertex Pharmaceuticals to Release 2024 Financial Results Soon
- Belo Sun Mining Expands Board with Strategic Appointment
- Aramark's Latest Quarterly Dividend Announcement and Impact
- Mawson Infrastructure Group Reports Remarkable Revenue Growth
- Harrow and Cencora Collaborate to Enhance Patient Care Access
- Fairness Investigation Launched for Logility Supply Chain Deal
- Anavex Life Sciences Expands Patent Portfolio for Innovative Treatment
- Captona Finalizes Major Energy Storage Initiative in Texas
- Market Trends Affect Dogecoin and Shiba Inu as Prices Fall
- Bowman Consulting Appoints Andy Dearing as New Leader in Aerial Imaging
- Hope Bancorp Unveils Quarterly Dividend Strategy for Investors
- Exciting Geochemical Discoveries at Pan Global's Cármenes Project
- Avianca Group Enhances Exchange Offer for Senior Secured Notes
- Exciting Soil Samples Yield High Gold and Copper at Cármenes
- Exciting Gold and Copper Discoveries at Cármenes Project
- HyperStrong Achieves a Successful Listing on STAR Market
- Trinity Capital Inc. Invests $30 Million in Innovative Tech Firm
- BTQ Technologies Advances Blockchain with Quantum Consensus Research
- Key Updates from Valmet's Shareholders' Nomination Board
- Navigating Economic Waters Amid Tariff Talks and Fed Decisions
- Discover 8.8% Dividends with These Strategic Funds
- Understanding Market Movements: Insights on the S&P 500
- Discovery Silver Expands Portfolio Acquiring Newmont's Assets
- SilverCrest Metals Gains Momentum with Positive Proxy Advisory
- EMERGE Commerce Celebrates Growth in Preliminary Q4 Financials
- Zoom Drain Seizes Opportunities with New Location in LA
- Franco-Nevada and Discovery Silver: A Winning Partnership Ahead
- Growing Popularity of Debt Settlement as a Financial Solution
- US Commercial & Residential Cleaning Services Market Growth
- Hopebridge Marks Two Decades of Transforming Autism Care
- Can-Fite's Namodenoson Patent: A Game Changer in Obesity Treatment
- Ncardia Unveils Ncyte Microglia for Neurodegenerative Research
- GT Biopharma's Groundbreaking Phase 1 Trial of GTB-3650 leads the way in Cancer Treatment